Algorae Pharmaceuticals Limited (ASX:1AI)
Australia
· Delayed Price · Currency is AUD 0.0060
0.00 (0.00%)
At close: Apr 17, 2025, 4:00 PM AEST
Algorae Pharmaceuticals Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Operating Revenue | - | - | - | 0 | 0.27 | 0.55 | Upgrade
|
| Other Revenue | 0.13 | 0.13 | 0.04 | - | - | - | Upgrade
|
| Revenue | 0.13 | 0.13 | 0.04 | 0 | 0.27 | 0.55 | Upgrade
|
| Revenue Growth (YoY) | 197.98% | 197.98% | 1133.95% | -98.73% | -51.56% | -28.06% | Upgrade
|
| Gross Profit | 0.13 | 0.13 | 0.04 | 0 | 0.27 | 0.55 | Upgrade
|
| Selling, General & Admin | 0.2 | 0.2 | 0.21 | - | - | - | Upgrade
|
| Research & Development | 0.63 | 0.74 | 1.31 | 1.46 | 1.61 | 2.38 | Upgrade
|
| Operating Expenses | 0.87 | 1.7 | 1.52 | 1.46 | 1.61 | 2.38 | Upgrade
|
| Operating Income | -0.74 | -1.58 | -1.48 | -1.46 | -1.34 | -1.83 | Upgrade
|
| Interest & Investment Income | 0.01 | - | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.03 | -0.02 | -0.02 | 0.01 | -0 | 0.3 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.53 | -0.5 | -0.61 | -0.91 | -0.67 | -0.77 | Upgrade
|
| EBT Excluding Unusual Items | -1.3 | -2.09 | -2.11 | -2.36 | -2.01 | -2.3 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 0.11 | 1.1 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0 | -0 | - | -0.01 | - | -0.15 | Upgrade
|
| Pretax Income | -1.3 | -2.1 | -2.11 | -2.37 | -1.91 | -1.35 | Upgrade
|
| Income Tax Expense | - | - | - | -0.41 | -0.44 | -0.38 | Upgrade
|
| Net Income | -1.3 | -2.1 | -2.11 | -1.96 | -1.46 | -0.97 | Upgrade
|
| Net Income to Common | -1.3 | -2.1 | -2.11 | -1.96 | -1.46 | -0.97 | Upgrade
|
| Shares Outstanding (Basic) | 1,687 | 1,663 | 1,347 | 876 | 571 | 571 | Upgrade
|
| Shares Outstanding (Diluted) | 1,687 | 1,663 | 1,347 | 876 | 571 | 571 | Upgrade
|
| Shares Change (YoY) | 10.68% | 23.47% | 53.82% | 53.24% | - | - | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Free Cash Flow | -1.22 | -1.52 | -1.99 | -2.05 | -1.46 | -3.11 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -592.03% | -1261.77% | -3521.03% | -42870.16% | -500.05% | -330.53% | Upgrade
|
| Profit Margin | -1036.09% | -1673.77% | -5016.32% | -57483.11% | -544.62% | -174.91% | Upgrade
|
| Free Cash Flow Margin | -970.66% | -1216.69% | -4727.46% | -60088.31% | -544.97% | -561.64% | Upgrade
|
| EBITDA | - | -1.58 | -1.48 | -1.46 | -1.34 | -1.81 | Upgrade
|
| D&A For EBITDA | - | 0 | 0 | 0 | 0 | 0.02 | Upgrade
|
| EBIT | -0.74 | -1.58 | -1.48 | -1.46 | -1.34 | -1.83 | Upgrade
|
| Revenue as Reported | 0.01 | - | - | - | - | - | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.